Correlates of protection against SARS-CoV-2 infection and COVID-19 disease

被引:176
|
作者
Goldblatt, David [1 ]
Alter, Galit [2 ]
Crotty, Shane [3 ,4 ]
Plotkin, Stanley A. [5 ]
机构
[1] UCL, Great Ormond St Inst Child Hlth, London, England
[2] Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Cambridge, MA USA
[3] La Jolla Inst Immunol LJI, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA
[4] Univ Calif San Diego UCSD, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA USA
[5] Univ Penn, Vaxconsult, 4650 Wismer Rd, Doylestown, PA 18902 USA
关键词
correlates; antibodies; fc effector; neutralization; T cells; CD4(+) T-CELLS; FC EFFECTOR FUNCTIONS; RECEPTOR-BINDING DOMAIN; NEUTRALIZING ANTIBODIES; VACCINE; INFLUENZA; IMMUNITY; MULTICENTER; INNATE;
D O I
10.1111/imr.13091
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies against epitopes in S1 give the most accurate CoP against infection by the SARS-CoV-2 coronavirus. Measurement of those antibodies by neutralization or binding assays both have predictive value, with binding antibody titers giving the highest statistical correlation. However, the protective functions of antibodies are multiple. Antibodies with multiple functions other than neutralization influence efficacy. The role of cellular responses can be discerned with respect to CD4(+) T cells and their augmentation of antibodies, and with respect to CD8(+) cells with regard to control of viral replication, particularly in the presence of insufficient antibody. More information is needed on mucosal responses.
引用
收藏
页码:6 / 26
页数:21
相关论文
共 50 条
  • [1] Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease Running title: Propolis against SARS-CoV-2 infection and COVID-19
    Berretta, Andresa Aparecida
    Duarte Silveira, Marcelo Augusto
    Capcha, Jose Manuel Condor
    De Jong, David
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [2] Protection against SARS-CoV-2 after COVID-19 vaccination and previous infection
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (04): : 211 - 211
  • [3] Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
    Hall, Victoria
    Foulkes, Sarah
    Insalata, Ferdinando
    Kirwan, Peter
    Saei, Ayoub
    Atti, Ana
    Wellington, Edgar
    Khawam, Jameel
    Munro, Katie
    Cole, Michelle
    Tranquillini, Caio
    Taylor-Kerr, Andrew
    Hettiarachchi, Nipunadi
    Calbraith, Davina
    Sajedi, Noshin
    Milligan, Iain
    Themistocleous, Yrene
    Corrigan, Diane
    Cromey, Lisa
    Price, Lesley
    Stewart, Sally
    de Lacy, Elen
    Norman, Chris
    Linley, Ezra
    Otter, Ashley D.
    Semper, Amanda
    Hewson, Jacqueline
    D'Arcangelo, Silvia
    Chand, Meera
    Brown, Colin S.
    Brooks, Tim
    Islam, Jasmin
    Charlett, Andre
    Hopkins, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13): : 1207 - 1220
  • [4] Vaccine against COVID-19 or against SARS-CoV-2 infection?
    Rieske, Piotr
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2020, 7 (03) : 131 - 145
  • [5] SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection
    Zervou, Fainareti N.
    Louie, Ping
    Stachel, Anna
    Zacharioudakis, Ioannis M.
    Ortiz-Mendez, Yadira
    Thomas, Kristen
    Aguero-Rosenfeld, Maria E.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5409 - 5415
  • [6] SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
    Dhakal, Bishnu P.
    Sweitzer, Nancy K.
    Indik, Julia H.
    Acharya, Deepak
    William, Preethi
    HEART LUNG AND CIRCULATION, 2020, 29 (07): : 973 - 987
  • [7] SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
    Costela-Ruiz, Victor J.
    Illescas-Montes, Rebeca
    Puerta-Puerta, Jose M.
    Ruiz, Concepcion
    Melguizo-Rodriguez, Lucia
    CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 54 : 62 - 75
  • [8] Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
    Samuel, Charles E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (08)
  • [9] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
    Shuo Feng
    Daniel J. Phillips
    Thomas White
    Homesh Sayal
    Parvinder K. Aley
    Sagida Bibi
    Christina Dold
    Michelle Fuskova
    Sarah C. Gilbert
    Ian Hirsch
    Holly E. Humphries
    Brett Jepson
    Elizabeth J. Kelly
    Emma Plested
    Kathryn Shoemaker
    Kelly M. Thomas
    Johan Vekemans
    Tonya L. Villafana
    Teresa Lambe
    Andrew J. Pollard
    Merryn Voysey
    Nature Medicine, 2021, 27 : 2032 - 2040
  • [10] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
    Feng, Shuo
    Phillips, Daniel J.
    White, Thomas
    Sayal, Homesh
    Aley, Parvinder K.
    Bibi, Sagida
    Dold, Christina
    Fuskova, Michelle
    Gilbert, Sarah C.
    Hirsch, Ian
    Humphries, Holly E.
    Jepson, Brett
    Kelly, Elizabeth J.
    Plested, Emma
    Shoemaker, Kathryn
    Thomas, Kelly M.
    Vekemans, Johan
    Villafana, Tonya L.
    Lambe, Teresa
    Pollard, Andrew J.
    Voysey, Merryn
    NATURE MEDICINE, 2021, 27 (11) : 2032 - +